Clinical trials
Phase 2 Lung Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2008 | 1 |
| 2012 | 4 |
| 2013 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 4 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Boehringer Ingelheim | 2 |
| Pfizer | 2 |
| Daiichi Sankyo | 1 |
| Eisai Inc. | 1 |
| Haruhiko Fukuda | 1 |
| Incyte Corporation | 1 |
| Japan Clinical Oncology Group | 1 |
| Japan Multinational Trial Organization | 1 |
| Kyoto University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 20 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Adenocarcinoma of Lung | 6 |
| Neoplasm Metastasis | 2 |
| Pancreatic Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.